Cargando...
Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches
BACKGROUND AND PURPOSE: Although botulinum toxin type A (BoNT/A) is approved for chronic migraine treatment, its mechanism of action is still unknown. Dural neurogenic inflammation (DNI) commonly used to investigate migraine pathophysiology can be evoked by trigeminal pain. Here, we investigated the...
Guardado en:
| Publicado en: | Br J Pharmacol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5341233/ https://ncbi.nlm.nih.gov/pubmed/26493010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13366 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|